AI assistant
IO Biotech, Inc. — Director's Dealing 2021
Nov 5, 2021
34883_dirs_2021-11-04_7fcecf4f-735a-4b83-8d9a-81f49ef781a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04
Reporting Person: Hirth Peter (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (Right to Buy) | $13.97 | Common Stock (4430) | Direct | ||
| Warrants (Right to Buy) | $15.36 | Common Stock (6513) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (13935) | Direct | ||
| Warrants (Right to Buy) | $19.62 | Common Stock (1265) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (17390) | Direct | ||
| Warrants (Right to Buy) | $12.64 | Common Stock (67162) | Direct |
Footnotes
F1: These Warrants vested in 25% annual increments on December 31 of each year following the November 23, 2016 grant date.
F2: Warrants expire in annual increments on the fifth anniversary of the vesting date.
F3: These Warrants vested in 25% annual increments on December 31 of each year following the February 21, 2017 grant date.
F4: These Warrants vest in 1/48 monthly increments after the May 27, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.
F5: These Warrants vest in 1/48 monthly increments after October 15, 2021 vesting commencement date, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.